Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?

被引：0
|
作者：
Eid M. El-Shafey
Said H. Abdou
Mohamed M. Shareef
机构：
[1] Tanta University Hospitals,Division of Nephrology, Department of Internal Medicine
[2] Tanta University,Department of Clinical Pathology
[3] Tanta University,Department of Pathology, Faculty of Medicine
[4] Tanta University,undefined
来源：
Clinical and Experimental Nephrology | 2010年 / 14卷
关键词：
Intravenous cyclophosphamide (IVC); Mycophenolate mofetil; Proliferative lupus nephritis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：214 / 221
页数：7
相关论文
共 50 条
  • [31] Mycophenolate mofetil compared with intravenous cyclophosphamide as induction treatment for pediatric lupus nephritis: A randomized trial
    Sundel, Robert P.
    Lisk, Laura
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S632 - S633
  • [32] A pharmacoeconomic study comparing the use of mycophenolate mofetil or cyclophosphamide as induction therapy in lupus nephritis patients in Egypt
    Khattab, Nada M.
    Abbassi, Maggie
    Raafat, Hala A.
    Farid, Samar
    [J]. LUPUS, 2022, 31 (04) : 505 - 516
  • [33] INTRAVENOUS CYCLOPHOSPHAMIDE (CP) PULSE THERAPY FOR LUPUS NEPHRITIS - DURATION OF INDUCTION THERAPY
    SCHAUMANN, D
    HEIN, R
    WITTE, T
    SCHMIDT, RE
    BRUNKHORST, R
    NEUMANN, KH
    DEICHER, H
    KOCH, KM
    [J]. KIDNEY INTERNATIONAL, 1993, 44 (01) : 249 - 249
  • [34] Mycophenolate mofetil for lupus nephritis refractory to cyclophosphamide
    Baños, I
    Yebra, M
    Fernández, J
    Cajal, YSR
    [J]. MEDICINA CLINICA, 2003, 121 (04): : 158 - 158
  • [35] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    Chan, TM
    Li, FK
    Tang, CSO
    Wong, RWS
    Fang, GX
    Ji, YL
    Lau, CS
    Wong, AKM
    Tong, MKL
    Chan, KW
    Lai, KN
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (16): : 1156 - 1162
  • [36] Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis
    Isenberg, DA
    Karassa, FB
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (05): : 382 - 383
  • [37] Sequential therapies with intravenous cyclophosphamide and oral mycophenolate mofetil or azathioprine are efficacious and safe in proliferative lupus nephritis - Comment
    Boumpas, DT
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (03) : 276 - 277
  • [38] EFFECT OF CYCLOPHOSPHAMIDE AND MYCOPHENOLATE MOFETIL ON LYMPHOCYTE SUBSETS IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS EFFECT OF CYCLOPHOSPHAMIDE AND MYCOPHENOLATE MOFETIL ON LYMPHOCYTE SUBSETS IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    Yap, Desmond Y. H.
    Lee, Paul
    Yam, Irene
    Tam, Chun Hay
    Wong, Sunny
    Yung, Susan
    Chan, Tak Mao
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [39] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Marwa Chbihi
    Laurye-Anne Eveillard
    Quentin Riller
    Romain Brousse
    Romain Berthaud
    Pierre Quartier
    Rémi Salomon
    Marina Charbit
    Marina Avramescu
    Nathalie Biebuyck
    Laurène Dehoux
    Nicolas Garcelon
    Jean-Paul Duong-Van-Huyen
    Brigitte Bader-Meunier
    Olivia Boyer
    [J]. Journal of Nephrology, 2023, 36 : 829 - 839
  • [40] Induction therapy for pediatric onset class IV lupus nephritis: Mycophenolate Mofetil versus Cyclophosphamide
    Chbihi, Marwa
    Eveillard, Laurye-Anne
    Riller, Quentin
    Brousse, Romain
    Berthaud, Romain
    Quartier, Pierre
    Salomon, Remi
    Charbit, Marina
    Avramescu, Marina
    Biebuyck, Nathalie
    Dehoux, Laurene
    Garcelon, Nicolas
    Duong-Van-Huyen, Jean-Paul
    Bader-Meunier, Brigitte
    Boyer, Olivia
    [J]. JOURNAL OF NEPHROLOGY, 2023, 36 (03) : 829 - 839
12345